News
Events
About Pompe Disease
Symptoms
Diagnosis
Pompe Registry
Resources
Patient-Focused Publications
Patients Helping Patients
Research Papers
Publications for Physicians
Testimonials
International Pompe Day
IPA Erasmus Pompe Survey
About the IPA
IPA Board
IPA Members & Contacts
IPA Community Advisory Board
IPA Reviews & Reports
IPA Conferences
IPA Position Papers
Contact
Events
Read our news
About Pompe Disease
Symptoms
Diagnosis
Pompe Registry
Resources
Patient-Focused Publications
Patients Helping Patients
Research Papers
Publications for Physicians
Testimonials
International Pompe Day
IPA Erasmus Pompe Survey
About the IPA
IPA Board
IPA Members & Contacts
IPA Community Advisory Board
IPA Reviews & Reports
IPA Conferences
IPA Position Papers
Contact us
Objectives to fulfill the mission
International Pompe Association objectives to fulfill its mission.
Author:
IPA
IPA Conferences
November 30, 1999
Report of the First Meeting of the International Pompe Association
An overview of the first meeting of the International Pompe Association in Naarden, the Netherlands.
Author:
IPA
IPA Conferences
November 30, 1999
Pompe´s Disease in Historical Perspective and the Way to Therapy
Dr. A.J.J. Reuser, and Dr. A.T. van der Ploeg discuss the history of Pompe disease and the way...
Author:
IPA
IPA Conferences
November 30, 1999
Clinical variability in Pompe’s disease
There are two main clinical variants of Pompe disease: The infantile form and the variant with late-onset.
Author:
IPA
IPA Conferences
November 30, 1999
Epidemiological studies in glycogen storage disease type II
Epidemiological studies and prevalence of Pompe disease.
Author:
IPA
IPA Conferences
November 30, 1999
Early detection and diagnosis of Pompe
Prof. Dr. J.J. Hopwood from Women’s and Children’s Hospital in Adelaide, Australia, discusses early diagnosis of Pompe disease.
Author:
IPA
IPA Conferences
November 30, 1999
A Transgenic Approach to Enzyme Replacement Therapy in Pompe Patients
Representatives from Pharming and Genzyme discuss their joint venture and the collaboration with physicians, patients and their families.
Author:
IPA
IPA Conferences
November 30, 1999
Treatment Strategies for Glycogen Storage Disease Type II
Dr. A. Amalfitano DO, PhD, from Duke University Medical Centre, discusses enzyme replacement therapy and the potential of...
Author:
IPA
IPA Conferences
November 30, 1999
The challenges of rhGAA manufacture
Dr. B. Devlin from Synpac (NC), Inc., USA discusses Synpac's commitment to bring a recombinant enzyme therapy for...
Author:
IPA
IPA Conferences
November 30, 1999
From patient initiative to treatment
Ms. M. Schoneveld van der Linde discusses the patient initiative to treatment for Pompe disease.
Author:
IPA
IPA Conferences
November 30, 1999
1
2
3